Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|January 10, 2024
The glymphatic system and cerebral small vessel diseasePhillip S Ang, Douglas M Zhang, Saara-Anne Azizi, et al.
Chemical Science|July 13, 2018
Construction of homogeneous antibody-drug conjugates using site-selective protein chemistryPadma Akkapeddi, Saara-Anne Azizi, Allyson M Freedy, et al.
ACS Chemical Biology|July 26, 2021
Development of an Acrylamide-Based Inhibitor of Protein <i>S</i>-AcylationSaara-Anne Azizi, Tong Lan, Clémence Delalande, et al.
Nature Chemical Biology|November 20, 2019
ABHD10 is an S-depalmitoylase affecting redox homeostasis through peroxiredoxin-5Yang Cao, Tian Qiu, Rahul S Kathayat, et al.
Bioorganic & Medicinal Chemistry|September 12, 2021
Antiviral evaluation of hydroxyethylamine analogs: Inhibitors of SARS-CoV-2 main protease (3CLpro), a virtual screening and simulation approachYash Gupta, Sumit Kumar, Samantha E Zak, et al.
Nature Communications|February 3, 2021
Structure of papain-like protease from SARS-CoV-2 and its complexes with non-covalent inhibitorsJerzy Osipiuk, Saara-Anne Azizi, Steve Dvorkin, et al.
Biorxiv : the Preprint Server for Biology|September 10, 2020
Drug repurposing screen identifies masitinib as a 3CLpro inhibitor that blocks replication of SARS-CoV-2 <i>in vitro</i>Nir Drayman, Krysten A Jones, Saara-Anne Azizi, et al.
Circulation Research|May 13, 2025
FoxO1-zDHHC4-CD36 S-Acylation Axis Drives Metabolic Dysfunction in DiabetesKaitlyn M J H Dennis, Keshav Gopal, Claudia N Montes Aparicio, et al.
Science Advances|January 20, 2022
Cannabidiol inhibits SARS-CoV-2 replication through induction of the host ER stress and innate immune responsesLong Chi Nguyen, Dongbo Yang, Vlad Nicolaescu, et al.
Pageof 3